Form 8-K NEUROCRINE BIOSCIENCES For: Feb 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Wall St futures mixed ahead of SK Hynix listing; Middle East in focus
- Oil heads for weekly gains as Middle East supply risks persist
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- The real reason Meta shares are surging has nothing to do with its new AI model
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
February 11, 2016 4:47 PM ESTNeurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of ($0.34), $0.02 worse than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
... More